Institutional experience using interstitial brachytherapy for the treatment of primary and recurrent pelvic malignancies

Abstract

The study assessed the outcomes of patients at a single institution with locally advanced primary and recurrent pelvic malignancies treated with interstitial high-dose-rate (HDR) or low-dose-rate (LDR) brachytherapy (BT), using a modified Syed-Neblett template.